Dr. Cellucci was an early pioneer in advancing the field of nanotechnology in American science, engineering and manufacturing. He was instrumental in progressing America’s nanotechnology agenda through his bi-partisan work with President Bill Clinton and George W. Bush and many leaders in the United States Senate. His contributions made possible the National Nanotechnology Initiative (NNI) signed by President George W. Bush in 2004 that added over $3.9 billion to the federal budget specific to the advancement of nanotechnology. From July 2007 to 2011, Dr. Cellucci served as the US Federal Government’s first ever Chief Commercialization Officer at the US Department of Homeland Security (DHS) and the White House, working directly for President George W. Bush and President Barack Obama. There he expanded the role of public-private partnerships within government and increased opportunities for cooperative research and development activities.
Who is running BVTK? Dr. Cellucci was an early pioneer
Dr. Cellucci was an early pioneer in advancing the field of nanotechnology in American science, engineering and manufacturing. He was instrumental in progressing America’s nanotechnology agenda through his bi-partisan work with President Bill Clinton and George W. Bush and many leaders in the United States Senate. His contributions made possible the National Nanotechnology Initiative (NNI) signed by President George W. Bush in 2004 that added over $3.9 billion to the federal budget specific to the advancement of nanotechnology. From July 2007 to 2011, Dr. Cellucci served as the US Federal Government’s first ever Chief Commercialization Officer at the US Department of Homeland Security (DHS) and the White House, working directly for President George W. Bush and President Barack Obama. There he expanded the role of public-private partnerships within government and increased opportunities for cooperative research and development activities.
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
European Residential REIT's 2024 Financial Performance Unpacked
Overview of European Residential REIT's Annual Results European Residential Real Estate Investment Trust (ERES) has released its results for the fiscal year ending December 31, 2024. This detailed report outlines the strategic measures taken throughout the year to enhance operational and financial performance. Key Events and Strategic Initiatives In a significant move,...
Continue Reading
Rogers Satellite: Expanding Communication Across Canada’s Landscape
Rogers Satellite Service Expands Nationwide Rogers has transformed cellular communication in Canada with the expansion of its innovative Rogers Satellite service. Now offering substantially more coverage than any competitor, Rogers Satellite redefines how Canadians connect, providing crucial services in remote and underserved regions. Enhanced Connectivity for Canadians...
Continue Reading
Info-Tech Research Group Announces Extended Awards Nominations
Extended Nomination Deadlines for Info-Tech Awards 2025 Info-Tech Research Group has announced an extension of the nomination deadlines for two prestigious categories in its annual awards program, which aims to highlight excellence within the dynamic field of IT leadership: Innovator of the Year and Women Leading IT. The Info-Tech Awards, revamped for 2025, celebrate the...
Continue Reading
FTSE 100 Trends: Energy and Mining Stocks Impact Market
FTSE 100 Overview The UK's primary stock index has recently experienced a downturn, largely driven by the performance of energy and mining shares. Investors are now looking ahead to an upcoming U.S. jobs report, which could significantly impact decisions regarding interest rate changes by the Federal Reserve. Current Market Performance The FTSE 100 index fell by 0.4%,...
Continue Reading
AIxMed Partners with Biopticka to Revolutionize Cytology Tools
AIxMed Forms Strategic Alliance with Biopticka Laborato? AIxMed Inc., a prominent force in computational cytology and AI diagnostics, has embarked on an exciting journey in collaboration with Biopticka Laborato? s.r.o., a leading private reference laboratory. This partnership aims to integrate AIxURO™, a groundbreaking AI-powered solution for urine cytology, into...
Continue Reading